Frank Sasinowski speaking at US Rare Diseases and Orphan Products Conference

Frank Sasinowski is speaking on “The Rising Power of the Patient’s Voice in Drug Development and FDA Actions on New Therapies” and on An Analysis of FDA’s Subpart H Approvals According to FDA’s Draft Guidance on Expedited Programs for Serious Conditions: FDA Flexibility Again!” at DIA’s US Rare Diseases and Orphan Products conference.

Bethesda North Marriott Hotel and Conference Center

Bethesda, MD